Avalon Globocare Corp
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About ALBT
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
Find out what a historical investment in Avalon Globocare Corp would be worth today using our ALBT stock calculator.
$5.70M
-
0.00%
34K
$1.43
$1.34
$1.38
$11.66
$1.21
Ready to start your investing journey with Stake?
Open an accountALBT FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ALBT
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ALBT
on Stake
Buy ALBT from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of ALBT from only US$10 with fractional shares
